Skip to main content
SpringerLink
Log in

The multiple sclerosis market

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: The global market for multiple sclerosis drugs.

Author information

Authors and Affiliations

  1. Navigant Life Sciences Consulting, 685 3rd Avenue, 14th Floor, New York, 10017, New York, USA

    Anders Westad, Aditya Venugopal & Eric Snyder

Authors
  1. Anders Westad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aditya Venugopal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Snyder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anders Westad.

Related links

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Westad, A., Venugopal, A. & Snyder, E. The multiple sclerosis market. Nat Rev Drug Discov 16, 675–676 (2017). https://doi.org/10.1038/nrd.2017.107

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.107

  • Springer Nature Limited

This article is cited by

Search

Navigation